
Recurrence Patterns and Clinical Management after a Positive Sentinel Node Biopsy in Melanoma Patients
2023; Taylor & Francis; Volume: 41; Issue: 10 Linguagem: Inglês
10.1080/07357907.2023.2283459
ISSN1532-4192
AutoresJacqueline Nunes Menezes, Dante A. S. M. Arra, Matheus Lobo, Clóvis A. Lopes Pinto, João Paulo da Silveira Nogueira Lima, Milton Barros, João P. Duprat Neto, Eduardo Bertolli,
Tópico(s)Allergic Rhinitis and Sensitization
ResumoIntroduction melanoma patients who become stage III after a positive sentinel node biopsy (SNB) may have several patterns of recurrence patients and methods retrospective analysis of melanoma patients who have undergone SNB in a single institution from 2000 to 2015. Results There were 111 recurrences (45.1%) among 246 (20.3%) SNB positive patients and median DRFS was 77.7 months. After initial treatment, further recurrences occurred in 68 (77.3%) patients, regardless the site of initial recurrence conclusions multimodal strategies are recommended to achieve better results when managing stage III melanoma patients after a positive SNB.
Referência(s)